AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ASPIRIN + PARACETAMOL + CAFFEINE

9 registrations across 4 African markets— 7 active

Markets with ASPIRIN + PARACETAMOL + CAFFEINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
Grand-Pa Headache Powders
Powder sachets
🇿🇲ZambiaGlaxoSmithKline South Africa (Pty) LtdactiveJul 2030
ACTION- COMBINATION PRODUCT TABLET
TABLET
🇲🇼MalawiexpiredMar 2025
A.P.C COMBINATION PRODUCT TABLET
TABLET
🇲🇼MalawiexpiredJun 2011
ASPIRIN + PARACETAMOL + CAFFEINE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaBETA HEALTH CARE INTERNATIONAL LTDactive
ASPIRIN + PARACETAMOL + CAFFEINE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaBETA HEALTH CARE INTERNATIONAL LTDactive
ASPIRIN + PARACETAMOL + CAFFEINE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaBETA HEALTH CARE INTERNATIONAL LTDactive
ASPIRIN + PARACETAMOL + CAFFEINE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaBETA HEALTH CARE INTERNATIONAL LTDactive
Cafenol Extra
Tablets
🇹🇿TanzaniaBeta Healthcare International Limitedactive
Homadex
Tablets
🇹🇿TanzaniaElys Chemical Industries Ltdactive

ASPIRIN + PARACETAMOL + CAFFEINE in Africa — Regulatory Overview

ASPIRIN + PARACETAMOL + CAFFEINE is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Malawi, Tanzania, Zambia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 7 (78%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.